A Machine Learning Model Trained on Dual-Energy CT Radiomics Significantly Improves Immunotherapy Response Prediction for Patients With Stage IV Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
A Machine learning model trained on dual-energy CT radiomics significantly improves immunotherapy response prediction for patients with stage IV melanoma
J Immunother Cancer 2021 Nov 01;9(11)xx, AS Brendlin, F Peisen, H Almansour, S Afat, T Eigentler, T Amaral, S Faby, AF Calvarons, K Nikolaou, AE OthmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.